25 November 2014
SCI's London Group in partnership with UCL's Chemical Physical Society
University College London, London, UK
This event is no longer available for registration.
With a focus on medicines currently used for the treatment of respiratory diseases, including asthma and bronchitis, this presentation will highlight several areas of drug discovery where organic chemists make key contributions. The relationship between chemical structure and the associated pharmacology of drug molecules across a range of biological target classes will be illustrated as will the importance of optimising physicochemical properties for the development of novel medicines.
Stephen Swanson, GlaxoSmithKlein, R&D Manager
Department of Chemistry
University College London
20 Gordon Street
London, WC1H 0AJ
Tel: 0207 598 1594
This is a FREE event. No need to book. Please check this page for any updates or changes before attending the event
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email email@example.com for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.